Literature DB >> 567046

Thrombohemolytic thrombocytopenic purpura during penicillamine therapy.

F Ahmed, V Sumalnop, D M Spain, M S Tobin.   

Abstract

Penicillamine therapy was associated with the development of thrombohemolytic thrombocytopenic purpura (TTP) in a 23-year-old woman. The immunological and hematological toxicity of penicillamine, as well as the occurrence of TTP with parent penicillin compounds, indicates a probable etiological role of this drug.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 567046

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Thrombotic thrombocytopenic purpura due to rifampicin.

Authors:  I H Fahal; P S Williams; R E Clark; G M Bell
Journal:  BMJ       Date:  1992-04-04

Review 2.  Thrombotic thrombo-cytopenic purpura associated with histamine H2-receptor antagonist therapy.

Authors:  S M Kallal; M Lee
Journal:  West J Med       Date:  1996-05

Review 3.  Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.

Authors:  I A Jaffe
Journal:  Springer Semin Immunopathol       Date:  1981

4.  [Thrombotic thrombocytopenic purpura (Moschkowitz-syndrome) caused by ticlopidine].

Authors:  J M Chemnitz; A Schulz; A Salameh; C Scheid; R Müller; A Draube; V Diehl; D Söhngen
Journal:  Med Klin (Munich)       Date:  2000-02-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.